Acute Multidisciplinary Imaging and Interventional Centre
The Acute Multidisciplinary Imaging and Interventional Centre (AMIIC) provides world-leading clinical research in parallel with high-end clinical services. Our aim is to deliver state-of-the-art multidisciplinary research by providing the research infrastructure linking interventional, non-invasive imaging (photon counting CT) and artificial intelligence/big data capabilities.
At the same time, the centre supports education and clinical training as well as clinical care, by working together with the Oxford University Medical Sciences Division and Oxford University Hospitals NHS Foundation Trust.
About AMIIC
The Acute Multidisciplinary Imaging and Interventional Centre (AMIIC) has been launched in its current form in June 2022, and is led by Professor Charalambos Antoniades, British Heart Foundation Chair of Cardiovascular Medicine at the University of Oxford. AMIIC comprises of three pillars: (a) Big Data/Artificial Intelligence (b) Advanced photon counting Computed Tomography Imaging (c) Invasive imaging and interventions (interventional suite).
Read moreWhat's new
AMIIC receives positive patient feedback
5 June 2023
AMIIC performs its first stroke thrombectomy
19 May 2023
AMIIC welcomes colleagues at opening event
13 January 2023
Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies
5 September 2022
RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.
UK's first photon-counting CT scanner arrives at AMIIC
15 February 2022
DPAG/RDM project wins Chan Zuckerberg Initiative funding
29 April 2020
Latest publications
-
Central adiposity increases risk of kidney stone disease via effects on serum calcium concentrations
Journal article
LOVEGROVE C. et al, (2023), Journal of the American Society of Nephrology
-
Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling
Journal article
Vales S. et al, (2023), Nature Communications, 14
-
The ongoing dilemma of prophylactic platelet transfusions pre-procedure and the development of evidence-based recommendations.
Journal article
Stanworth SJ. et al, (2023), Transfus Med
-
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Journal article
Đukić N. et al, (2023), Sci Adv, 9
Selected publications
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data.
Journal article
Oikonomou EK. et al, (2018), Lancet, 392, 929 - 939
